Skip to main content

Table 1 Impact of heterologous CsTKS on P. tricornutum’s metabolism

From: Impact of heterologous expression of Cannabis sativa tetraketide synthase on Phaeodactylum tricornutum metabolic profile

Analyte

Chemical 2D structure

Family

Biosynthesis/metabolic route

Norvaline Betaine

Amino Acid dipeptide

Pyruvate Isoleucine pathway and choline oxidation reactions [44, 46,47,48]

Thiamine*

Vitamin/Cofactor

Vitamin B6, glycine, pyruvate and purine metabolism [44, 49]

Quinolizine

Alkaloid/Quinolizine

Unsolved, possible pyridine derived precursor, Malonyl-CoA and a Polyketide synthase [50]

Methyl 2-[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]propanoate

Coumarin Derivative

Shikimate Pathway [44, 51]

Thiamine Pyrophosphate

Vitamin/Cofactor

Pyruvate and purine metabolism [44, 49]

Alanylphenylalanine

Amino Acid dipeptide

Shikimate Pathway [44, 52]

2-Hydroxyacetophenone

Organic aromatic alkyl-phenylketones/Benzoic Acid

Putative Shikimate and polyketide Pathway [53]

Guanine

Nucleic Acid

Nucleotide metabolism [44, 54, 55]

Thermopsine

Alkaloid/Quinolizidine

Lysine decarboxylation [50, 56]

  1. The presence of CsTKS alters the activity of key metabolic pathways, including the shikimate pathway, nucleotide metabolism, and amino acid metabolism. Metabolites highlighted in pink-orange are all upregulated, while those in blue are downregulated. Analytes are listed in descending order of fold change. The “Biosynthesis/metabolic route” column emphasizes shared pathways or biosynthetic routes among the identified analytes